Hypertension evaluation

Slides:



Advertisements
Similar presentations
Treatment of Hypertension
Advertisements

Chronic kidney disease
Chronic kidney disease
Summary Prepared by Melvyn Rubenfire, MD
The Seventh Report of the Joint National Committee on the Prevention, Detection, Evaluation, and Treatment of High Blood Pressure Internal Medicine/Pediatrics.
DIABETES AND THE KIDNEYS
Hypertension. Hypertension or high blood pressure is a chronic medical condition in which the blood pressure in the arteries is elevated. This requires.
CKD In Primary Care Dr Mohammed Javid.
National Institute for Health and Clinical Excellence.
This lecture was conducted during the Nephrology Unit Grand Ground by Medical Student rotated under Nephrology Division under the supervision and administration.
A retrospective cohort study of Childhood post-streptococcal glomerulonephritis as a risk factor for chronic renal disease in later life Andrew V White,
© Copyright Annals of Internal Medicine, 2014 Ann Int Med. 161 (6): ITC6-1. * For Best Viewing: Open in Slide Show Mode Click on icon or From the View.
Lesley Stevens MD Tufts-New England Medical Center
© Continuing Medical Implementation …...bridging the care gap Target Organ Damage Joel Niznick MD FRCPC.
Hypertension: JNC 7 Guidelines Steven W Harris MHS PA-C.
Early Detection and Prevention of Renal Failure Linda Fried, MD, MPH.
Implementing NICE guidance
Hypertension in Childhood: Diagnosis & Management.
Systemic Hypertension. Systemic blood pressure measures 140/90 mm Hg or higher on at least two occasions a minimum of 1 to 2 weeks apart.
Perioperative Testing
2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults: A Report of the American College.
Definitions and classification of office blood pressure levels (mmHg) Modified by ESC Guidelines 2013 CARDIOcheckAPP.
Dr M Sivalingam Renal Unit, Lister Hospital, Stevenage.
Radka Adlová Arterial hypertension and preventive cardiology.
Although in more than 90% of patients with high blood pressure no underlying causes could be identified, up to 10% of hypertensives have a secondary.
Hypertension BP ≥140/90 (WHO/ISH,1993) Isolated systolic hypertension: BP syst ≥ 140 mm Hg, BP diast. < 90 mm Hg.
Section IV. Routine and Optional Laboratory Tests for the Investigation of Patients with Hypertension 2015 Canadian Hypertension Education Program Recommendations.
Section III. Assessment of Overall Cardiovascular Risk in Hypertensive Patients 2015 Canadian Hypertension Education Program Recommendations.
Preoperative Hemoglobin A1c and the Occurrence of Atrial Fibrillation Following On-pump Coronary Artery Bypass surgery in Type-2 Diabetic Patients Akbar.
Trial profile Mann JF et al. Lancet 2008;372:
MACROVASCULAR COMPLICATIONS, DYSLIPIDEMIA and HYPERTENSION 2003 Clinical Practice Guidelines for the Prevention and Management of Diabetes in Canada.
Relationship between coronary and renal artery disease and associated risk factors in hypertensive and diabetic patients undergoing coronary angiography.
Diabetes and the Kidney Richard Kingston Department of Renal Medicine Kent and Canterbury Hospital.
Dr.Ruba Nashawati. Diabetes  Leading cause of ESRD  30% 40%  DN  DN Risk type I = type II.
1 Dr. Zahoor Ali Shaikh. HYPERTENSION DEFINITION  Hypertension is said to be present when blood pressure is greater than expected for a person of particular.
Date of download: 5/28/2016 Copyright © The American College of Cardiology. All rights reserved. From: 2013 ACC/AHA Guideline on the Treatment of Blood.
The MICRO-HOPE. Microalbuminuria, Cardiovascular and Renal Outcomes in the Heart Outcomes Prevention Evaluation Reference Heart Outcomes Prevention Evaluation.
Left Ventricular Filling Pressure by Doppler Echocardiography in Patients With End-Stage Renal Disease Angela Y-M Wang, Mei Wang, Christopher W-K Lam,
Risk Factors for Renal Dysfunction in Type 2 Diabetes: U.K. Prospective Diabetes Study 74 Ravi Retnakaran, Carole A Cull, Kerensa I Thorne, Amanda I Adler,
OPD follow up 1. General P/E Blood pressure Sites of insulin injection Deep tendon reflex 2.
Indication Contraindication Preparation
The presence of cardiovascular disease is an important predictor of mortality in patients with end-stage renal disease, as it accounts for almost 50 percent.
Date of download: 9/18/2016 Copyright © The American College of Cardiology. All rights reserved. From: ACCF/ASNC/ACR/AHA/ASE/SCCT/SCMR/SNM 2009 Appropriate.
Powered by Infomedica Infomedica Conference Coverage* of 26 th European Meeting on Hypertension and Cardiovascular Protection Paris (France), June 10-13,
신장내과 R4 강혜란 Cardiorenal syndrome (CRS).  Patients with heart failure (HF) who have a reduced GFR -> Mortality ↑  Patients with chronic kidney disease.
Screening System for Hypertension and Diabetes at Primary Care Level
Dr John Cox Diabetes in Primary Care Conference Cork
Figure 1.1 Prevalence of CKD by stage among NHANES participants,
From ESH 2016 | LB 3: Davide Agnoletti, MD
Redefining Quality Care in T2DM Patients with CV Disease
Hypertension JNC VIII Guidelines.
Hypertension by Tina Bobek, R.N.
Baseline characteristics and effectiveness results
All-cause mortality by treatment group
Chapter 1: CKD in the General Population
Hypertension Hanna K. Al-Makhamreh, MD FACC Interventional Cardiology.
Cholesterol practice questions
L. Aya M. Serry Glomerulonephritis 2017
Basic laboratory testing
Diabetes Health Status Report
Neil J. Stone et al. JACC 2014;63:
The percentage of subjects with de novo development of renal function impairment (GFR
Diuretics, Kidney Diseases Urine R&M
Panelists. One Size May Not Fit All: A New Aspirin Option for the High-Risk Patient.
The Hypertension in the Very Elderly Trial (HYVET)
Type 2 diabetes: Overlap of clinical conditions
2 Preliminary Health Screening and Risk Classification chapter 2
Section 5: Configuration of healthcare to manage CKD
Contemporary Evidence-Based Guidelines
KS-CGMH Guideline for Hyperlipidemia
Presentation transcript:

Hypertension evaluation By jamshid najafian

history 1-Duration of hypertension. "How long have you had high blood pressure?" "When was the last time you were told your blood pressure was normal?“ 2-History of prior treatment for hypertension 3-Nonadherence to antihypertensive

physical examination The main goals 1- Evaluate for signs of end-organ damage (such as retinopathy) Ocular effects of hypertension The various pulses should be palpated Abdomen should be auscultated for a renal artery bruit. The presence of an upper-abdominal bruit with a diastolic component that lateralizes toward one side is highly suggestive of renal artery stenosis. 2- Evidence of a cause of identifiable hypertension .

The 2008 every patient with hypertension should have The brachial and femoral pulses palpated simultaneously to assess timing and amplitude to evaluate for brachial-femoral delay characteristic of coarctation of the aorta . In addition, supine bilateral arm (brachial artery) blood pressures and prone right or left supine leg (popliteal artery) blood pressures should be measured to search for differential pressure.

Laboratory testing   The procedures that should be routinely performed to evaluate 1- Underlying causes 2- Signs of end-organ damage 3- Cardiovascular risk

Blood chemistries 1- Electrolytes 2- Glucose 3- creatinine. 4- An estimated glomerular filtration rate (eGFR) 5- Lipid profile Most hypertensive patients will have hyperlipidemia or sufficiently elevated cardiovascular risk to indicate statin therapy 6- Urinalysis to detect hematuria and an albumin/creatinine ratio to estimate albumin excretion.

ekg If there are abnormalities in EKG of patient with severe hypertension, an Attempt should be made to determine whether they are new or were previously documented The patient with acute changes generally requires more aggressive blood pressure reduction

Tests that are occasionally performed Ambulatory blood pressure monitoring  The main indication for its use is in the patient with persistent office hypertension but normal out-of-office blood pressure readings. Echocardiography   Routine echocardiographic evaluation of hypertensive patients is not recommended, unless there are specific indications, such as clinically evident heart failure, or if left ventricular dysfunction or coronary artery disease is suspected . Echocardiography is a more sensitive method to detect left ventricular hypertrophy than EKG. .

Tests that are occasionally performed Serum uric acid   Hyperuricemia has been found to be a precursor and possible pathogenetic factor for hypertension It is not known whether the presence of hyperuricemia or its treatment will influence the management of hypertension. Plasma renin activity   Although the plasma renin activity (PRA) , the test is usually performed only in patients with possible low-renin forms of hypertension, such as primary mineralocorticoid excess. The PRA may provide guidance in the evaluation and treatment of resistant hypertension Workup for renovascular hypertension  Additional testing for renovascular disease is indicated only in patients in whom the history is suggestive (table 1). The identification of patients who should be evaluated for renovascular hypertension and the diagnosis of renovascular hypertension in such patients are presented in detail elsewhere

Albuminuria   In patients with hypertension, moderately increased albuminuria (formerly, microalbuminuria) is associated with an increased incidence of cardiovascular disease. The value of measuring albumin excretion in patients with primary hypertension without diabetes is being increasingly advocated to assess cardiovascular risk however, it does not have value as a screening tool for nephropathy in nondiabetic patients with hypertension

ASSESSMENT OF CARDIOVASCULAR RISK  — As well defined by data from the Framingham study, a number of other risk factors interact with hypertension to determine the overall risk status of each individual patient . The presence or absence of other risk factors can influence the decision as to whether to institute antihypertensive medications in a patient with borderline values . Several calculators are available to estimate overall cardiovascular risk (calculator 1 and calculator 2 and calculator 3). The atherosclerotic cardiovascular disease (ASCVD) risk calculator may be more strongly associated with cardiovascular outcomes than other calculators